News

Medico Intercontinental Ltd share price softened by 1.27% to Rs 28.01 after the company`s net profit jumped 73.19% to Rs 4.07 crore, while revenue from operations eased by 7.91% to Rs 20.71 crore in Q2FY26 over Q1FY26. The market capitalization of Trading & Distributors industry group stocks on BSE stood at Rs 49691.37 crore, falling 11.57%. It has slipped by 0.67% over last one week and jumped by 24.91% in last one month while the market capitalization of Medico Intercontinental Ltd has eased by 3.35% and 21.84% in the same period respectively. Profit before tax (PBT) of Medico Intercontinental Ltd stood at Rs 3.68 crore in Q2 FY26, surging by 83.08% year-on-year, and rallying 137.42% quarter-on-quarter. EBITDA came in at Rs 1 crore, nosediving by 300.00% YoY and plunging by 154.67% sequentially. Total expenses posted a minor rise of 1.39% to Rs 22.61 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 2.79 crore, advancing by 18.72% YoY, while employee benefits expense was at Rs 2.56 crore, soaring 13.78% YoY. For the TTM ended FY26, revenue from operations surged 33.58% to Rs 95.32 crore, while net profit saw a strong growth of 25.57% to Rs 4.96 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 492% to Rs 7.77 crore, and PBT witnessed a strong rise of 25.37% to Rs 6.82 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 7.11 crore in FY26, as against Rs 5.58 crore in FY25. Medico Intercontinental Ltd nosedived by 22.06% in last one year, underperforming the benchmark BSE Sensex which has slipped by 3.05% during the same period.

Medico Intercontinental will hold a meeting of the Board of Directors of the Company on 14 August 2026.

Net loss of Medico Intercontinental reported to Rs 0.65 crore in the quarter ended March 2026 as against net profit of Rs 1.17 crore during the previous quarter ended March 2025. Sales rose 6.29% to Rs 22.49 crore in the quarter ended March 2026 as against Rs 21.16 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 3.20 crore in the year ended March 2026 as against net profit of Rs 5.06 crore during the previous year ended March 2025. Sales declined 11.79% to Rs 84.08 crore in the year ended March 2026 as against Rs 95.32 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales22.4921.16 6 84.0895.32 -12 OPM %7.169.17 -3.548.58 - PBDT-0.131.75 PL -3.917.61 PL PBT-1.551.47 PL -9.346.82 PL NP-0.651.17 PL -3.205.06 PL Powered by Capital Market - Live News

Medico Intercontinental will hold a meeting of the Board of Directors of the Company on 22 May 2026.

Net loss of Medico Intercontinental reported to Rs 0.22 crore in the quarter ended December 2025 as against net profit of Rs 1.17 crore during the previous quarter ended December 2024. Sales rose 7.70% to Rs 19.85 crore in the quarter ended December 2025 as against Rs 18.43 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales19.8518.43 8 OPM %8.0110.31 - PBDT0.031.80 -98 PBT-1.401.57 PL NP-0.221.17 PL Powered by Capital Market - Live News